Novavax vaccine

Novavax vaccine under rolling review by the EMA

News

 * 04 Aug 2021, Politico.eu, Commission approves Novavax coronavirus vaccine deal — finally, The announcement caps more than a year and a half of talks.
 * 14 Jun 2021, Politico.eu, Novavax’s coronavirus vaccine proves more than 90 percent effective, The protein-based jab also proved to be 100 percent effective in preventing moderate and severe disease. The catch: The vaccine won’t be on the market soon. The U.S. company said it won’t submit to regulators until the third quarter of the year — by which point, the vast majority of Europeans, Britons and Americans should already be vaccinated.